Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the study's history.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:51.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and the entry for v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T16:40:48.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history; the notices about funding and operating status and the prior Revision: v3.4.1 entry were removed. These are administrative updates that do not alter the core study content or data on the page.
    Difference
    0.8%
    Check dated 2026-02-11T02:29:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added and the page revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-03T23:29:04.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Glossary visibility is added and change diffs are shown with color highlights (green for additions, red for deletions), and the revision label updated to v3.4.0.
    Difference
    1%
    Check dated 2026-01-27T22:03:20.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' entries were removed from the footer/versions view; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T07:38:15.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.